Hypercholesterolemia and Atherosclerosis in Primary Biliary Cirrhosis: What Is the Risk?
Abstract
ABSTRPlCT: Hypercholesterolemia is commonly associated with primary biliary cirrhosis. In the general population, elevated serum cholesterol is associated with an increased risk of atherosclerosis. The relative risk has been poorly defined in primary biliary cirrhosis patients with hyperlipidemia. In addition, the hyperlipidemic state seen with primary biliary cirrhosis has not been well studied. We prospectively observed 312 patients with primary biliary cirrhosis for a median of 7.4 yr. During this period, 128 patients died. The incidence of atherosclerotic death in patients with primary biliary cirrhosis was not statistically different when compared with an age–matched and sex–matched U.S. control population. A similar group of 50 consecutive PBC patients had detailed serum lipid profiles. Findings included progressive increases in total cholesterol and low–density lipoprotein cholesterol with an increasing histological stage or severity of disease. High–density lipoprotein cholesterol was elevated in all stages, with the highest levels in histological stage 2 and 3 disease. Triglycerides were normal or slightly elevated in all stages. Apoprotein A–I was elevated in all but histological stage 4 disease. Our study suggests the hyperlipidemia associated with primary biliary cirrhosis does not place these patients at risk for atherosclerotic death. In light of the limitations imposed by our relatively small sample size, however, additional patients should be studied. Furthermore, an examination of the pathophysiological mechanisms leading to hypercholesterolemia should be the topic of further study. (Hepatology 1992;15:858-862).
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There is no robust evidence to suggest that ischaemic heart disease or other forms of atherosclerotic disease are seen at increased frequency in PBC despite elevation of cholesterol.
“Despite elevation of cholesterol being a frequent feature in PBC, there is no robust evidence to suggest that ischaemic heart disease or other forms of atherosclerotic disease are seen at increased frequency in the condition.115–118”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [115]
Cites
Diminished survival in asymptomatic primary biliary cirrhosis
Balasubramaniam, K., Grambsch, P. M., Wiesner, R. H., Lindor, K. D., & Dickson, E. R. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91091-j · Cited by 141 · see citing works
Self-citationParadoxical elevation of serum cholesterol by clofibrate in patients with primary biliary cirrhosis
Schaffner, F. (1969) · Gastroenterology · doi:10.1016/s0016-5085(19)33896-x · Cited by 33 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099 · see citing works
Self-citationCarey, E. J., Ali, A. H., & Lindor, K. D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00154-3 · Cited by 735 · see citing works
Self-citationPrince, M., Chetwynd, A., Newman, W., Metcalf, J. V., & James, O. F. W. (2002) · Gastroenterology · doi:10.1053/gast.2002.36027 · Cited by 348 · see citing works
Hirschfield, G. M., Dyson, J. K., Alexander, G. J. M., Chapman, M. H., Collier, J., Hübscher, S., Patanwala, I., Pereira, S. P., Thain, C., Thorburn, D., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315259 · Cited by 347 · see citing works
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis
Longo, M., Crosignani, A., Battezzati, P. M., Squarcia Giussani, C., Invernizzi, P., Zuin, M., & Podda, M. (2002) · Gut · doi:10.1136/gut.51.2.265 · Cited by 190 · see citing works
Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort
Jones, D. E. J., Bhala, N., Burt, J., Goldblatt, J., Prince, M., & Newton, J. L. (2006) · Gut · doi:10.1136/gut.2005.080317 · Cited by 136 · see citing works
Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers
Ritzel, U., Leonhardt, U., Näther, M., Schäfer, G., Armstrong, V. W., & Ramadori, G. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00006-5 · Cited by 94 · see citing works
Allocca, M., Crosignani, A., Gritti, A., Ghilardi, G., Gobatti, D., Caruso, D., Zuin, M., Podda, M., & Battezzati, P. M. (2006) · Gut · doi:10.1136/gut.2005.079814 · Cited by 92 · see citing works
Ungprasert, P., Wijarnpreecha, K., Ahuja, W., Spanuchart, I., & Thongprayoon, C. (2015) · Hepatology Research · doi:10.1111/hepr.12452 · Cited by 34 · see citing works
- Authors
- Crippin, J. S., Lindor, K. D., Jorgensen, R., Kottke, B. A., Harrison, J. M., Murtaugh, P. A., & Dickson, R. E.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Lindor, Kieth D.
- ORCID
- Crippin, Jeffrey S.
- Venue
- Hepatology
- Published
- 1992-05
- Volume
- 15
- Issue
- 5
- Pages
- 858-862
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1996203016
- Cited by
- 149
- References
- 2
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 6 · 2018: 9 · 2017: 5 · 2016: 4 · 2015: 6 · 2014: 5 · 2013: 2 · 2012: 4
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Keywords
- primary biliary cirrhosis, hypercholesterolemia, hyperlipidemia, atherosclerosis, serum cholesterol, LDL cholesterol, HDL cholesterol, apolipoprotein A-I, triglycerides, disease severity, histological stage, cardiovascular risk
- MeSH terms
- Adult, Aged, Arteriosclerosis, Cholesterol, Female, Humans, Hypercholesterolemia, Lipoproteins, Liver Cirrhosis, Biliary, Male, Middle Aged, Prospective Studies, Risk Factors, Triglycerides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review